Gynecological Cancer Clinical Research and Trials
Research-Driven Treatment Starts with Clinical Trials
Leading therapies at University Hospitals Seidman Cancer Center often result from the groundbreaking research done in clinical trials at our center. These research studies explore new treatments and medications. Clinical trials have the potential to benefit the patients involved in the study. They also can help future gynecologic cancer patients once the results of the clinical trial are known.
At any given time, UH Seidman Cancer Center is conducting 25 to 30 clinical trials for women with gynecologic cancer or at high risk of developing gynecologic cancer. This research includes trials for women with newly diagnosed or recurrent cancers, as well as studies aimed at preventing gynecologic cancers or improving the accuracy of early diagnosis.
Because of its focus on leading research, UH Seidman Cancer Center has five times the national average of clinical trial participation. If we determine that a patient is a good candidate for one of these studies, she may be invited to volunteer to participate in a clinical trial.
Leading Health Care Organizations Recognize UH Seidman Cancer Center Research
The gynecologic oncologists at UH Seidman Cancer Center are members of the National Institutes of Health (NIH)-sponsored Gynecologic Oncology Group (GOG). Because of this designation, UH Seidman Cancer Center patients have access to the latest, highly specialized NIH-sponsored clinical research.
The National Cancer Institute (NCI) has named UH Seidman Cancer Center as one of the few centers in the country allowed to conduct Phase I clinical trials for women with gynecologic cancer. The research done at UH Seidman Cancer Center is used to help develop additional trials on a nationwide basis.